Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 3,293.90
-49.05 (-1.47%)
At close: Sep 4, 2026
Kwality Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 673.46 | 398.45 | 237.96 | 193.72 | 1,200 |
Depreciation & Amortization | 198.1 | 182.9 | 195.59 | 149.58 | 106.91 |
Loss (Gain) From Sale of Assets | -7.12 | -0.28 | -0.02 | -0.54 | - |
Other Operating Activities | 135.46 | 82.47 | 230.67 | 60.91 | 30.91 |
Change in Accounts Receivable | -1,257 | -399.2 | -426.91 | -25.64 | - |
Change in Inventory | 52.13 | -50.78 | 27.35 | -329.54 | -359.96 |
Change in Accounts Payable | 458.93 | 114.76 | 91.25 | 6.78 | - |
Change in Other Net Operating Assets | -87.65 | 198.87 | 73.95 | 358.55 | -371.81 |
Operating Cash Flow | 165.86 | 527.18 | 429.83 | 413.82 | 605.97 |
Operating Cash Flow Growth | -68.54% | 22.65% | 3.87% | -31.71% | 126.91% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -446.02 | -232.93 | -298.41 | -476.73 | -551.52 |
Sale of Property, Plant & Equipment | 32.42 | 0.76 | 41.12 | 18.63 | - |
Sale (Purchase) of Intangibles | -43.39 | -17.1 | - | - | - |
Other Investing Activities | 107.89 | -35.89 | -6.67 | -26.3 | -77.75 |
Investing Cash Flow | -349.1 | -285.15 | -263.97 | -484.41 | -629.28 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 316.93 | 87.94 | 40.56 | 115.48 | 85.74 |
Total Debt Issued | 316.93 | 87.94 | 40.56 | 115.48 | 85.74 |
Long-Term Debt Repaid | -136.83 | -133.57 | -112.59 | -45.34 | - |
Total Debt Repaid | -136.83 | -133.57 | -112.59 | -45.34 | - |
Net Debt Issued (Repaid) | 180.1 | -45.62 | -72.03 | 70.14 | 85.74 |
Other Financing Activities | -109.7 | -98.78 | -101.95 | -60.2 | -29.17 |
Financing Cash Flow | 70.4 | -144.4 | -173.98 | 9.94 | 56.57 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | 0 |
Net Cash Flow | -112.84 | 97.62 | -8.12 | -60.65 | 33.26 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -280.15 | 294.25 | 131.42 | -62.92 | 54.45 |
Free Cash Flow Growth | - | 123.91% | - | - | 64.69% |
Free Cash Flow Margin | -5.57% | 7.95% | 4.28% | -2.51% | 1.19% |
Free Cash Flow Per Share | -27.00 | 28.36 | 12.66 | -6.06 | 5.25 |
Levered Free Cash Flow | -539.91 | -64.32 | -130.94 | -258.69 | -225.56 |
Unlevered Free Cash Flow | -471.34 | -2.58 | -66.02 | -221.06 | -207.33 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 109.7 | 98.78 | 101.95 | 60.2 | 29.17 |
Cash Income Tax Paid | 207.67 | 157.9 | 13 | 61.56 | 413.54 |
Change in Working Capital | -834.05 | -136.35 | -234.36 | 10.14 | -731.77 |